AG1 just dropped its first non-greens products: AG Omega3 and AG Omega3 + CoQ10. Wild-caught fish source. The single-SKU brand is officially becoming a platform.

AG1 added two new products to its lineup: a standalone AG Omega3 and a combined AG Omega3 + CoQ10. Both are sourced from wild-caught fish with the same "rigorously tested" framing AG1 has used for the flagship Greens. The expansion is meaningful because AG1 has been the canonical example of the one-SKU, $99-a-month subscription daily routine brand for nearly a decade. Every brand-strategy person in CPG has at some point argued that AG1's restraint (resisting the obvious temptation to launch protein, hydration, sleep, or sub-categories) was the entire moat. That posture just changed.

Whether AG1 can stretch into adjacent supplements without diluting the core ritual is the question every prestige and wellness CPG operator should be watching. The bull case is obvious: AG1 has roughly 10 years of subscription customer data, knows exactly which adjacent purchases its core consumer is making, and can underwrite new SKU launches with internal first-party data that no competitor has. The bear case is also clear: the second a one-SKU brand becomes a multi-SKU brand, it stops being a daily routine and starts being a regimen, which is a different consumer behavior. Omega 3 is also the most price-compressed supplement category in the wellness aisle right now (Nordic Naturals, Thorne, Carlson, Ritual, plus every Whole Foods private label). AG1's pricing power has been built on the closed-loop subscription. Pricing power doesn't usually port into a category this commoditized.

Is AG1 expanding its core moat or breaking it? And for any one-SKU subscription brand reading this: at what scale does sticking to a single product start to cap you vs. protect you? Where's the line?

Source - CPG Wire